Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Nexstim Oyj's FCF Yield % or its related term are showing as below:
STU:5NX'
s FCF Yield % Range Over the Past 10 Years
Min: -2052.01 Med: -20.19 Max: 0.35
Current: -0.39
During the past 13 years, the highest FCF Yield % of Nexstim Oyj was 0.35%. The lowest was -2052.01%. And the median was -20.19%.
STU:5NX's FCF Yield % is ranked worse than 50.18% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: -0.36
vs STU:5NX: -0.39
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Nexstim Oyj FCF Yield % Related Terms
Nexstim Oyj FCF Yield % Historical Data
* Premium members only.
The historical data trend for Nexstim Oyj's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nexstim Oyj's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexstim Oyj FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nexstim Oyj's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Nexstim Oyj's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexstim Oyj (STU:5NX) has a FCF Yield % of -0.39 as of Sep. 07, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nexstim Oyj and its competitors. According to the industry distribution chart, Nexstim Oyj ranks #425 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 50.2%.
Is Nexstim Oyj's FCF Yield % too high?
Nexstim Oyj's current FCF Yield % is -0.39. Based on the distribution chart, Nexstim Oyj ranks #425 out of 847 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nexstim Oyj has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Nexstim Oyj's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nexstim Oyj ranks #425 out of 847 companies for FCF Yield %. This places Nexstim Oyj in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nexstim Oyj and its competitors. Nexstim Oyj's current FCF Yield % is -0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexstim Oyj stock overvalued right now?
Nexstim Oyj (STU:5NX) has a current FCF Yield % of -0.39. The stock's GF Value™ is €8.18, compared to a current price of €9.45 — trading 15.5% above its estimated fair value. The current FCF Yield % is -0.39. Nexstim Oyj's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Nexstim Oyj (STU:5NX), the current FCF Yield % is -0.39 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexstim Oyj (STU:5NX) Overvalued in 2026?
Based on GuruFocus' analysis, Nexstim Oyj stock appears to be overvalued.
The current stock price of €9.45 is trading 15.5% above its estimated GF Value™ of €8.18.
Key valuation signals for STU:5NX:
FCF Yield %: -0.39
GF Value™: €8.18 vs. price of €9.45 (15.5% above fair value)
No single metric tells the full story. See the STU:5NX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.
61GF Score
Get the complete analysis for STU:5NX
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:5NX has been successfully added to your 
